210 related articles for article (PubMed ID: 36726110)
21. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs.
Xu J; Yu SJ; Sun S; Li YP; Zhang X; Jin K; Jin ZB
Glia; 2024 May; 72(5):872-884. PubMed ID: 38258347
[TBL] [Abstract][Full Text] [Related]
22. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
23. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
24. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
26. The role of intravitreal chemotherapy for retinoblastoma.
Manjandavida FP; Shields CL
Indian J Ophthalmol; 2015 Feb; 63(2):141-5. PubMed ID: 25827545
[TBL] [Abstract][Full Text] [Related]
27. Reconstruct Human Retinoblastoma In Vitro.
Zhang X; Jin ZB
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36314812
[TBL] [Abstract][Full Text] [Related]
28. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
29. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
30. Clinical findings and molecular diagnosis of retinoblastoma in older children.
Sheck LH; Ng YS; Watson M; Vincent AL
Ophthalmic Genet; 2013 Dec; 34(4):238-42. PubMed ID: 23289805
[TBL] [Abstract][Full Text] [Related]
31. Retinal pigment epithelium exhibits gene expression and phagocytic activity alterations when exposed to retinoblastoma chemotherapeutics.
Cerna-Chavez R; Rozanska A; Poretti GL; Benvenisty N; Parulekar M; Lako M
Exp Eye Res; 2023 Aug; 233():109542. PubMed ID: 37331647
[TBL] [Abstract][Full Text] [Related]
32. Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.
Antczak C; Kloepping C; Radu C; Genski T; Müller-Kuhrt L; Siems K; de Stanchina E; Abramson DH; Djaballah H
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3065-73. PubMed ID: 19151399
[TBL] [Abstract][Full Text] [Related]
33. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p.
Yao L; Yang L; Song H; Liu TG; Yan H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3526-3537. PubMed ID: 32329826
[TBL] [Abstract][Full Text] [Related]
34. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma.
Venkatesan N; Kanwar JR; Deepa PR; Navaneethakrishnan S; Joseph C; Krishnakumar S
Chem Biol Interact; 2016 May; 252():141-9. PubMed ID: 27062892
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
36. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
39. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
40.
Kanber D; Woestefeld J; Döpper H; Bozet M; Brenzel A; Altmüller J; Kilpert F; Lohmann D; Pommerenke C; Steenpass L
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
